Edition:
United Kingdom

People: Faurecia SE (EPED.PA)

EPED.PA on Paris Stock Exchange

40.13EUR
19 Jul 2019
Change (% chg)

€2.31 (+6.11%)
Prev Close
€37.82
Open
€38.22
Day's High
€40.68
Day's Low
€38.22
Volume
663,439
Avg. Vol
601,469
52-wk High
€65.20
52-wk Low
€30.06

de Rosen, Michel 

Mr. Michel de Rosen has served as Chairman of the Board of Faurecia S.A. since May 30, 2017. He is Chairman of the Governance Committee as of May 29, 2018. He started serving as Director of the Company on May 27, 2016. He is a graduate of HEC and Ecole Nationale d'Administration. Over the course of his career, he has successively held positions first as a senior public official and then as a senior executive at companies in France and the United States. He began his career at the Inspectorate General of Finance (IGF), a division of the French Ministry of Finance. He was an advisor to the French Minister of Defense between 1980 and 1981 and served as Chief of Staff for the French Minister for Industry and Telecommunications from 1986 to 1988. Within the REone-Poulenc group, he served as Chief Executive Officer of Pharmuka from 1983 to 1986 and of Rhone Poulenc Fibres et Polymeres from 1988 to 1993, after which he was Chief Executive Officer and then Chairman and Chief Executive Officer of Rhone Poulenc Rorer in the United States and in France and of Rhone Poulenc Sante from 1993 to 1999. In 2000, Mr. Michel de Rosen was named Chairman and Chief Executive Officer of the US company ViroPharma. He became Chairman and Chief Executive Officer of SGD in 2008, before joining Eutelsat in 2009. On July 1, 2009, Mr. Michel de Rosen was appointed as Deputy Chief Executive Officer of Eutelsat and then as Chief Executive Officer and Board member on November 9 of the same year. Mr. Michel de Rosen served as Chairman of the Board of Directors of Eutelsat Communications S.A until 2017.

Basic Compensation

Total Annual Compensation, EUR 300,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 4,982
Fiscal Year Total, EUR 304,982

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --